Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-128800 in moderate to severe plaque psoriasis
NCT00852670Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Covalent Small Molecules, Molecular Glues, Classical Binding Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ponesimod in plaque psoriasis, sponsored by Actelion Pharmaceuticals Ltd. Started Oct 2008; status: completed.
02
Drugs
ponesimod
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00852670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852670.